Yusuke Nakamura to Cyclic Nucleotide Phosphodiesterases, Type 4
This is a "connection" page, showing publications Yusuke Nakamura has written about Cyclic Nucleotide Phosphodiesterases, Type 4.
Connection Strength
0.195
-
A genome-wide association study identifies four genetic markers for hematological toxicities in cancer patients receiving gemcitabine therapy. Pharmacogenet Genomics. 2012 Apr; 22(4):229-35.
Score: 0.108
-
Lack of association between variations of PDE4D and ischemic stroke in the Japanese population. Stroke. 2009 Apr; 40(4):1245-51.
Score: 0.087